Menu
Not yet recruiting NCT06431295

Evaluation of a Digital Visual Acuity Device vs. Standard Visual Acuity Measurements

No phase Interventional Visual Acuity

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: FaceScan.
Who it may be relevant to
Registry conditions: Visual Acuity. Basic parameters: from 18 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
United States
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Unsure about the terms? Read our patient guide →

Official title

Human Performance Evaluation of a Digital Visual Acuity Device: Visual Acuity-001

Overview

The purpose of this research is to validate and determine the accuracy of the experimental device when measuring visual acuity versus our standard visual acuity measurements and to gather voice recordings of letters to help build a special system that recognizes spoken letters.

Interventions

  • Device FaceScan
    Digital visual acuity device built for iOS ("iPhone") that conducts an assessment of visual acuity using a combination of integrated light detection and ranging (LiDAR) and voice processing.

Primary outcome measures

  • Number of times the experimental device when measuring visual acuity agreed with standard visual acuity measurements [Time frame: Baseline]
Secondary outcome measures (1)
  • Voice samples [Time frame: Baseline]

Eligibility criteria

Inclusion criteria

  • Adult patients (≥ 18 years) who come to Ophthalmology Clinic.
  • Willing and able to provide consent.

Exclusion criteria

  • Individuals < 18 years of age.
  • Unable to provide consent.

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: Yes

Study design

Allocation
N/A
Model
Single group
Masking
Open label
Primary purpose
Screening

Study locations

United States · 1 center
  • Mayo Clinic in Florida — Jacksonville

Identifiers

NCT: NCT06431295 · 23-007148

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗